跳至主要内容
临床试验/ITMCTR2024000032
ITMCTR2024000032已完成1 期

The anti-inflammatory effects of Mahajak oil in patients with acute gout attack; Pilot study

Artina Pinta and all other members of the research group0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
31 至 85(—)
性别
All

入选标准

  • Patients were eligible for the trial if they had been clinically diagnosed with acute gout arthritis according to the Rome criteria for gout, i.e. with at least 2 of the following 4 criteria: (1) serum urate (SU) level >7 mg/dL in men or >6 mg/dL in women; (2) presence of tophi; (3) presence of monosodium urate (MSU) crystals in synovial fluid or tissues; (4) history of painful joint swelling with abrupt onset and remission within 2 weeks.11 Male or female patients aged 20 years or above, without any diseases or contraindications to the interventions, no skin diseases, and no prior joint accidents were included. Patients were required to give written informed consent and to agree to follow the protocol.

排除标准

  • Patients with secondary gout or other types of arthritis such as rheumatoid arthritis, osteoarthritis, or septic arthritis, as well as those suffering from SLE were excluded from the study. Patients with a history of hypersensitivity to herbal medicines were also excluded.

研究者

发起方
Artina Pinta and all other members of the research group

相似试验